Key result
Doppler echocardiography estimation of pulmonary artery systolic pressure showed strong correlation (r=0.781) and high diagnostic efficacy (AUC 0.98) compared to right heart catheterization for screening pulmonary hypertension.
Why the study?
This study aimed to explore the accuracy and influencing factors of noninvasive pulmonary artery systolic pressure assessment by Doppler echocardiography using right heart catheterization as reference.
Does Doppler echocardiography accurately estimate pulmonary artery systolic pressure compared to right heart catheterization in patients suspected of pulmonary hypertension?
Observational (n=218)
Blinded investigators
No
Does Doppler echocardiography accurately estimate pulmonary artery systolic pressure compared to right heart catheterization in patients suspected of pulmonary hypertension?
Effect estimate: r 0.781
p-value: p=<0.001
Doppler echocardiography provides an accurate noninvasive estimation of pulmonary artery systolic pressure, though its accuracy is highly dependent on tricuspid regurgitation signal quality.
Echocardiography may aid noninvasive pulmonary hypertension screening; leaves open prospective validation needs given signal quality dependence.
Purpose This study aimed to explore the accuracy and influencing factors of noninvasive assessment of pulmonary artery systolic pressure by Doppler echocardiography (sPAPECHO) with right heart catheterization (RHC) as reference. Methods A total of 218 highly suspected pulmonary hypertension (PH) patients who underwent RHC and echocardiography within 7 days were included. The ratio of (sPAPECHO-sPAPRHC)/sPAPRHC was calculated and divided into three groups, namely, the underestimation group, accurate group and overestimation group by ± 10% as the boundary. The correlation and consistency between tricuspid regurgitation (TR) derived parameters and RHC results were tested by Pearson and Bland-Altaman methods. With mPAP ≥ 25mmHg measured by RHC as the standard diagnostic criteria of PH, ROC curve was used to evaluate the diagnostic efficacy. The influencing factors of sPAPECHO were analyzed by ordered regression analysis. Results sPAPECHO had the greatest correlation coefficient (r = 0.781, P < 0.001) and best diagnostic efficiency (AUC = 0.98) compared with other TR related methods. Bland-Altman analysis demonstrated the bias of sPAPECHO (mean bias = 0.07mmHg, 95% limits of agreement: -32.08 to + 32.22mmHg) was lower than that of TR-PG (mean bias = 5.87mmHg, 95% limits of agreement: -26.46 to + 38.21mmHg). The results of ordered regression analysis showed that TR signal quality, PAWP and sPAPRHC level affected the accuracy of sPAPECHO (P < 0.05). Relative to the signal quality of type A, the OR value of type B and C signal quality were 0.26 (95%CI: 0.14, 0.48) and 0.23 (95%CI: 0.07, 0.73), respectively. The OR value of PAWP was 0.94 (95%CI: 0.89, 0.99). Compared with high sPAPRHC level, the OR value of low and medium sPAPRHC level were 21.56 (95%CI: 9.57, 48.55) and 5.13 (95%CI: 2.55, 10.32), respectively. Conclusion sPAPECHO was superior than other TR-related methods in screening PH. TR signal quality is vital for accurate assessment of sPAPECHO. For patients with pre-capillary disease, a higher echocardiographic threshold is more suitable for determining the possibility of PH, especially during the initial stage of disease.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2021) conducted an observational in Pulmonary hypertension (n=218). Doppler echocardiography (sPAPECHO) vs. Right heart catheterization (RHC) was evaluated on Correlation between sPAPECHO and sPAPRHC (r 0.781, p=<0.001). Doppler echocardiography estimation of pulmonary artery systolic pressure showed strong correlation (r=0.781) and high diagnostic efficacy (AUC 0.98) compared to right heart catheterization for screening pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: